ALS therapeutics (Nippon Sanofi)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug NameALS therapeutics (Nippon Sanofi)
Drug Alias Nameamyotrophic lateral sclerosis therapy (Nippon Sanofi)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi Kk
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi Kk
Active IndicationsN/A
Inactive IndicationsAmyotrophic Lateral Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A